Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,822
Out of 4,829 analysts
18
Total ratings
8.33%
Success rate
-41.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Life Sciences | Initiates: Buy | $18 | $1.44 | +1,150.00% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $17.52 | -2.97% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $3.91 | +769.57% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $110.16 | -13.76% | 2 | Nov 1, 2022 | |
| SAGE Sage Therapeutics | Initiates: Hold | $41 | $6.77 | +505.61% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $0.61 | +226.42% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $33 | $0.27 | +12,259.55% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $1.55 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $2.20 | +1,357.86% | 4 | Dec 16, 2020 |
Atai Life Sciences
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $1.44
Upside: +1,150.00%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $17.52
Upside: -2.97%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $3.91
Upside: +769.57%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $110.16
Upside: -13.76%
Sage Therapeutics
Nov 1, 2022
Initiates: Hold
Price Target: $41
Current: $6.77
Upside: +505.61%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $0.61
Upside: +226.42%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $33
Current: $0.27
Upside: +12,259.55%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.55
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $2.20
Upside: +1,357.86%